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Aims To examine the heritability of atrial fibrillation (AF) in Icelanders, utilizing a nationwide genealogy
database and population-based data on AF. AF is a disorder with a high prevalence, which has been
known to cluster in families, but the heritability of the common form has not been well defined.
Methods and results The study population included 5269 patients diagnosed since 1987 and age-
sex-matched controls randomly selected from the genealogy database. Kinship coefficients (KC),
expressed as genealogical index of familiality (GIF ¼ average KC  100 000), were calculated before
and after exclusion of relatives separated by one to five meiotic events. Risk ratios (RR) were calculated
for first- to fifth-degree relatives. The average pairwise GIF among patients with AF was 15.9 (mean
GIF for controls 13.9, 95%CI ¼ 13.3, 14.4); this declined to 15.4 (mean GIF for controls 13.6,
95%CI ¼ 13.1, 14.2) after exclusion of relatives separated by one meiosis and to 13.7 (mean GIF for con-
trols 12.6, 95%CI ¼ 12.1, 13.2), 12.7 (mean GIF for controls 11.9, 95%CI ¼ 11.4, 12.4), and 11.3 (mean
GIF for controls 10.6, 95%CI ¼ 10.1, 11.1) after exclusion of relatives within two, three, and four
meioses, respectively (all P, 0.00001). RRs among relative pairs also declined incrementally, from
1.77 in first-degree relatives to 1.36, 1.18, 1.10, and 1.05 in second- through fifth-degree relatives
(all P, 0.001), consistent with the declining proportion of alleles shared identically by descent.
When the analysis was limited to subjects diagnosed with AF before the age of 60, first-degree relatives
of the AF cases were nearly five times more likely to have AF than the general population.
Conclusion AF shows strong evidence of heritability among unselected patients in Iceland, suggesting






Atrial fibrillation (AF) is a common arrhythmia associated
with increased mortality and significant morbidity.1,2 As AF
is primarily a disease of the elderly, its prevalence is
expected to increase with the advancing age of Western
populations.3 Multiple risk factors have been implicated,
including hypertension, coronary artery disease, and elev-
ated CRP.4,5 However, AF is known to occur in the absence
of these conditions6 and there is some evidence of familial
clustering,7 suggesting a genetic component to the risk of
the disease, especially in patients with lone AF.
Although a few studies have identified Mendelian variants
in selected families, which increase susceptibility to AF,8–11
none has yet uncovered variants that underlie the common
form of the disease. A recent report from the Framingham
Study described increased risk in offspring of patients with
AF, but only parent/offspring risk was assessed and the
number of offspring cases was small.12 Demonstration of
familial clustering in unselected families is an important
first step towards the study of genetic contribution to the
risk of the common form of AF.
Icelanders are relatively homogeneous with respect to
both genetic and environmental factors, they have an acces-
sible health-care system and extensive genealogical records
covering the entire nation,13 all features that render
population-wide heritability studies of conditions such as
AF feasible. In this study, these resources were leveraged
to address the following objectives: (i) to compare the
degree of relatedness of AF patients to a random population
sample by assessing the kinship coefficient (KC); (ii) to assess
the risk ratio (RR) of AF among relatives at varying degrees
of genetic distance; and (iii) to determine the strength and
consistency of these risk relationships in AF patients above
and below the age of 60 at the time of diagnosis.
Methods
Patients
All patients diagnosed with AF at the Landspitali University Hospital
from 1987 to 2003, the only tertiary referral centre in Iceland and
the only hospital in Reykjavik (where two-thirds of the population
resides), were included in this study. Diagnoses were confirmed by
a 12-lead electrocardiogram demonstrating no P waves and irregu-
larly irregular R–R intervals. All electrocardiograms were manually
read by a cardiologist. All AF cases diagnosed during the time
period were included regardless of whether the patients had clinical
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symptoms or not. Although detailed phenotypic information was not
available for the cohort, we stratified patients on the basis of age
,60 or 60 years at the time of diagnosis of AF. This was done
because some include in their definition of lone AF an age limit
,60 years,6 whereas others do not include an age limit in their defi-
nition.14 It has been demonstrated that the prevalence of heart
disease in Iceland increases substantially after the age of 60.15,16
Given this, individuals under the age of 60 at the time of diagnosis
are more likely to have lone AF than those over the age of 60. Thus,
dividing the group in this way might give an idea of the potential
heritability of lone AF vs. AF associated with organic heart disease,
although this clearly relies on some assumptions. The data currently
do not allow further subclassification of the arrhythmia as
paroxysmal, persistent, or permanent.
The study protocol was approved by the National Bioethics
Committee of Iceland and the Icelandic Data Protection Authority.
Genealogical database
The Icelandic genealogy database contains records on 716 000 indi-
viduals, more than half the adult population of Iceland since the
settlement of the island more than 11 centuries ago.17 It includes
all living Icelanders, more than 284 000 individuals, and a large
proportion of their ancestors back to 930 AD.13 This allows investi-
gation of various levels of relatedness among patients as well as
recruitment of population-based control groups.17
According to studies based on Y-chromosome and mitochondrial
polymorphisms, 75% of males who settled in Iceland were
Norwegian and 66% of females were Celtic.18–20 Although the
island has been relatively isolated since its settlement, autosomal
recessive disorders, which are frequently seen in inbred popu-
lations, have not been prevalent in Iceland.
Assessment of inheritance
The average pairwise KC was calculated for AF patients and com-
pared to the distribution of the average KC for a set of controls
matched one to one for sex, year of birth (5-year strata), and
numbers of ancestors in the genealogy database five generations
back. KC is the probability that two randomly selected alleles at
an autosomal locus, one from each individual, are inherited from
a common ancestor.21 KCs were refined by excluding the contri-
bution by close relatives, as these are more likely to share the
environment and may dominate the results22 and the resulting
values were compared to the distribution of values of 100 000
matched control groups. In this study, a control group refers to a
sample selected randomly from our genealogy database of individ-
uals matching the patients in sex, year of birth (rounded to 5
years), and connectivity in the genealogy database (same number
of ancestors five generations back). These control groups are not
ascertained for any phenotype, and we use between 10 000 and
100 000 randomly chosen such control groups. They serve the
purpose of estimating confidence intervals for the RR and KC esti-
mates, respectively, not in obtaining the estimates for RR and KC
themselves. KCs were expressed as genealogical index of familiality
(GIF ¼ average KC  100 000).23
The RR for relatives of affected patients was defined as the risk of
the disease in the relatives divided by the risk in the general popu-
lation. This ratio is directly related to the power to map suscepti-
bility genes.24 Obtaining valid estimates of the RR are not
straightforward because many sampling schemes and inappropriate
estimators can lead to biased or inflated estimates.25,26 The use of
population-based groups of patients eliminates much of the poten-
tial sampling bias, and a near-complete genealogy database facili-
tates identification of patients related to other patients. From the
distribution of RR calculated for 10 000 matched controls sets,22
95%CIs were estimated. Heritability was also assessed separately
for AF patients aged ,60 and 60 at the time of the diagnosis
of arrhythmia. For both KCs and RRs, a P-value of ,0.05 was
considered significant.
The software used for familiality calculations was developed at
deCODE.26
Results
A total of 5269 patients were diagnosed with AF during the study
period, and of those, 914 (17.3%) were under 60 years at the time
of diagnosis of AF. The mean age of patients was 71.6 years
(SD ¼ 13.6). There were 3110 (59%) males and 2159 (41%)
females. Eighty per cent of patients (n ¼ 4195) were related
within four meioses to another patient, with the four largest
family clusters including 728, 130, 114, and 107 patients. Figure 1
shows a representative cluster of AF patients in one of the affected
families.
GIF values were higher among AF patients than among controls,
including when relatives within six or less meioses were excluded
(Table 1); all P, 0.00001 except when excluding relatives within
six meioses (P ¼ 0.00003). GIFs for AF patients diagnosed at age
,60 were also higher than for controls, with P, 0.00001 for
GIFs with none or first-level relatives removed and maintained
significance until fifth or higher level relations were excluded.
Results for AF patients aged 60 were similar to those for the
full cohort.
First-degree relatives of AF patients were 1.77-fold more likely
to have AF than the general population (Table 2). RRs declined
incrementally by degree of relationship (but remained signifi-
cantly above 1.0) in second- through fifth-degree relatives, con-
sistent with the proportion of alleles shared identically by
descent.
First-degree relatives of patients ,60 years of age were more
than four-fold (RR ¼ 4.67) more likely to have AF at age ,60 than
the general population. Second-degree relatives of those patients
were also more likely to have AF at age ,60 than the general popu-
lation. More distant relatives demonstrated the same pattern but
there is not sufficient power in the study to claim significance.
For those diagnosed at the age 60, the RR was greater than 1.0
for all relatives, although this did not reach statistical significance
for fourth- and fifth-degree relatives and again declined incremen-
tally, with excess risk falling by about a factor of 2 with each dimin-
ishing degree of relatedness.
Discussion
This population-based cohort of over 5000 patients with AF shows
significant familial clustering by two robust analytic methods,
KC and RR, strongly suggesting a familial basis for the condition.
This observation extends well beyond second-degree relatives
(grandparents/grandchildren, aunts/uncles, nephews/nieces,
half-siblings), suggesting that the impact of the common home
environment is likely to be small.27
To our knowledge, only one other population-based cohort of AF
cases has been used to estimate heritability of the condition and
that focused exclusively on parent–offspring RRs.12 Ascertainment
of parent–offspring risk of AF is complicated in most contemporary
studies by the difficulties of ascertaining late-onset disease in
previous generations. The Framingham Heart Study solved this
problem by having essentially complete, prospective ascertainment
of AF among both parents and offspring.2 The current study solved
this by using recent diagnoses among contemporaries and using a
genealogy database to link them through familial relationships to
a number of previous generations.13
We observed an exponential decline in RR by degree of related-
ness, consistent with diminishing proportion of alleles shared iden-
tically by descent. Evidence of a graded association such as this is
considered to be among the strongest of the epidemiological criteria
for causal inferences.28 The Icelandic data are unique in permitting
reliable assessment of RRs at such distant levels of relatedness.
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Although patients diagnosed at an age of ,60 comprised only 17%
of the sample, evidence of heritability was stronger in the younger
group, at least among more closely related persons. This might
imply that (i) the genetics of AF in patients aged 60 is more
complex and different from those under 60; (ii) lone AF is not repre-
sentative of common AF in its familial clustering; or (iii) the sample
size of the cohort ,60 years of age is insufficient to demonstrate all
but the strongest risks. This supports the value of examining herit-
ability on a population basis, with a broad definition of phenotype.
The present study has several limitations, most notably a lack of
detailed information on other risk factors for AF and the lack of cat-
egorization of the subtype of AF. The results, nevertheless, strongly
suggest that genetic factors contribute to the risk of all AF. The
heritability of hypertension and coronary artery disease, both
known risk factors for AF, has also been well documented, and the
possibility that these risk factors underlie, at least in part, the famil-
ial clustering observed for AF obviously has to be considered. The
aetiology of AF is likely multi-factorial, with a number of cardio-
vascular comorbidities known to increase the risk of AF. It is also
well known that AF can occur in those with no demonstrable heart
disease. The limitations to the data presented here need to be
addressed in future studies with detailed phenotyping of the cohort.
Although other investigators have mainly focused on lone AF in
familial studies,7–11 our previous work in myocardial infarction29
and stroke30 lends additional support to the value of initial studies
using broadly defined phenotypes in the context of our genealogy
database. In both diseases, an initial approach with a broad pheno-
type has led to discoveries of genes that confer risk of myocardial
infarction and stroke.29,30 Thus, we anticipate that our AF studies
may also offer a novel insight into the pathogenesis of AF and
point towards new therapeutic possibilities.
The substantial population burden of undifferentiated AF, which is
expected to increase significantly in the coming years,3 underscores
the need for exploration of a broadly defined phenotype. Indeed, the
results presented in this study using a broad phenotype indicate a
familial component to the common form of AF. As the results of the
pharmacological therapy for AF are somewhat unsatisfactory and
access to ablative therapy limited, exploring new therapeutic
options for this common disorder is important. Further understanding
of the molecular mechanisms of AF is crucial in developing new strat-
egies in dealing with the significant public health burden caused by
the disease. Detailed phenotyping of the cohort and linkage analysis
in search of AF susceptibility genes are necessary steps to further
understand the genetic contribution to the common form of AF.
Figure 1 A large representative pedigree showing 69 patients with AF. Filled circles represent affected females and filled squares affected males. Slash marks
denote family members listed in the local death registry. The AF patients presented could be traced to common ancestors less than or equal to six previous
generations.
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In conclusion, we have demonstrated substantial familial aggrega-
tion of AF in Iceland and strong likelihood of heritability among
unselected AF patients, suggesting that there may be undiscovered
genetic variants underlying the risk of the common form of AF. The
observation that these results relate to both younger patients and
those over 60 years of age indicates that these results might be
generalizeable to all AF populations.
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